Aug 2026· Neurobiology of Disease· pp.
107568
· 0 citations· 56 references
Medicine
TL;DR
A pre-plaque, cell-type-specific synaptic phenotype in male APP/PS1 mice is defined in which impaired mGluR1/5-dependent plasticity and persistent CP-AMPAR signaling in D1R+ MSNs coincide with selective reward-related alterations.
Abstract
Alzheimer's disease (AD) is increasingly associated with early circuit dysfunction preceding cognitive decline, including neuronal hyperactivity and neuropsychiatric symptoms linked to mesolimbic pathways. The nucleus accumbens (NAc), a central regulator of reward and motivational processing, exhibits early alterations in excitation/inhibition balance in patients and experimental models, yet the synaptic mechanisms underlying its vulnerability remain unclear. Using a double transgenic APP/PS1 mice crossed with a Drd1a-tdTomato reporter line, we combined cell-type-specific electrophysiology, immunohistochemistry, ex vivo photometry, and behavioral assays. At a pre-plaque stage, intraneuronal Aβ accumulated in both dopamine D1 receptor-positive (D1R+) and D1R-negative medium spiny neurons (MSNs). Despite comparable Aβ levels, both high-frequency stimulation-induced long-term depression (LTD) and mGluR1/5-dependent LTD were selectively impaired in D1R+ MSNs. This vulnerability was accompanied by an increased contribution of calcium-permeable AMPA receptors (CP-AMPARs). Subsequent CP-AMPAR blockade reduced the residual evoked excitatory postsynaptic current that persisted after mGluR1/5 activation in APP/PS1 D1R+ MSNs. Because paired-pulse ratios remained unchanged, this residual response was consistent with a predominantly postsynaptic mechanism. These synaptic changes were accompanied by reduced evoked dopamine signaling, increased chocolate consumption, and altered baseline context preference, whereas standard pellet consumption, conditioned place preference, anxiety-like behavior, and social behavior were unchanged. These findings define a pre-plaque, cell-type-specific synaptic phenotype in male APP/PS1 mice in which impaired mGluR1/5-dependent plasticity and persistent CP-AMPAR signaling in D1R+ MSNs coincide with selective reward-related alterations.
By restoring neurotrophic signaling and dopaminergic function, PT320 represents a promising therapeutic strategy for PD-related anxiety and depression by restoring neurotrophic signaling and dopaminergic function in the nucleus accumbens.
Kuan-Yin Tseng, Tung-Tai Kuo, P. Chang et al.· Journal of Parkinson's Disea...· 0 citations
The results indicated that the magnitude of mGluR-LTD induced by the group I mGluRs agonist (S)-3,5-dihydroxyphenylglycine (DHPG) was smaller in JDM rats than in age-matched control rats, which indicates that the expression of mGluR-LTD in JDM rats may be associated with presynaptic changes.
Dopaminergic depletion appears to enhance network excitation and disrupt mGluR1/5-mediated control of M1 surface circuitry in hemi-parkinsonian rats, identifying altered cortical surface mGluR-dependent plasticity in the hemi-parkinsonian model.
Hongseong Shin, Yoon Ji Kwon, Hyunjung Hwang et al.· International Journal of Mol...· 0 citations
D2R signaling is identified as a major determinant of iMSN structural and intrinsic physiological integrity and global loss of D2R function reproduces many of the adaptations induced by dopamine depletion, indicating that dopamine depletion drives distinct forms of plasticity through separable D2R dependent and indepen...
Samuel Alberquilla, Carlos Salas Prieto, Paula Merino Serrais et al.· Neurobiology of Disease· 0 citations
Results indicate that decreased Aβ42 in NE-depleted mice stems not from altered DA but from NE loss, highlighting the NE-mediated regulation of endogenous Aβ42 and the role of NE in AD-related pathology.
Isaiah Hoffman, Jennifer A. Ross, M. Tumasz et al.· MedScience· 0 citations
Progranulin-related frontotemporal dementia (
GRN
-FTD) is an inherited neurodegenerative disorder caused by progranulin (PGRN) deficiency. Although PGRN functions are well characterized and several therapeutic strategies aiming to restore its levels are currently under evaluation, the mechanisms linking PGRN los...
Chiara Bertasini, Maria Italia, Shima Tavakolian Haghighi et al.· Acta Neuropathologica Commun...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.